0001453687-19-000111.txt : 20190816
0001453687-19-000111.hdr.sgml : 20190816
20190816161657
ACCESSION NUMBER: 0001453687-19-000111
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190125
FILED AS OF DATE: 20190816
DATE AS OF CHANGE: 20190816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farokhzad Omid
CENTRAL INDEX KEY: 0001586852
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37798
FILM NUMBER: 191033669
MAIL ADDRESS:
STREET 1: C/O BIND THERAPEUTICS, INC.
STREET 2: 325 VASSAR ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SELECTA BIOSCIENCES INC
CENTRAL INDEX KEY: 0001453687
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-923-1400
MAIL ADDRESS:
STREET 1: 480 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4/A
1
wf-form4a_156598660162280.xml
FORM 4/A
X0306
4/A
2019-01-25
2019-03-29
0
0001453687
SELECTA BIOSCIENCES INC
SELB
0001586852
Farokhzad Omid
C/O SELECTA BIOSCIENCES, INC.
480 ARSENAL WAY
WATERTOWN
MA
02472
1
0
0
0
Common Stock
25626
I
See Footnote
Common Stock
202051
I
See Footnote
Common Stock
188004
D
These shares were omitted from the Reporting Person's original Form 4 filed on March 29, 2019.
These securities are held by BioDynamics Core, L.P., which is managed by BioDynamics, LLC, of which the Reporting Person is a member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
These securities are held by SAF-SEL Trust, for which the Reporting Person's spouse serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
/s/ Matthew Bartholomae, Attorney-in-Fact for Omid Farokhzad
2019-08-16